No Data
No Data
Is Viking Therapeutics Inc. (VKTX) the Best Performing Small-Cap Stock in 2024?
Oppenheimer points out the next "trend" for weight loss drugs: oral over-the-counter medication.
The competition to develop oral weight-loss drugs is intensifying.
Why Viking Therapeutics Stock Was So Healthy on Wednesday
Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
Next Frontier in Anti-obesity Landscape: Oral GLP-1s With Potential OTC Switch
Viking Therapeutics Analyst Ratings